February 23, 2021
3 min read
Disclosures: DeGette and Griffith report no relevant financial disclosures. Dobber, Hoge, Nettles, Trizzino and Young are employed by the pharmaceutical companies they represented.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
ADDED TO EMAIL ALERTS
We were unable to process your request. Please try again later. If you continue to have this issue please contact firstname.lastname@example.org.
Back to Healio
Pharmaceutical executives from Pfizer, Moderna, Johnson & Johnson, AstraZeneca and Novavax testified Tuesday that they are on track to deliver a combined 1.1 billion doses of COVID-19 vaccine in the United States by the end of July.
The executives answered questions from a House Energy & Commerce subcommittee on oversight and investigations. Their testimony came as the pace of the U.S. vaccine rollout continues to increase after a slow start.
Novavax Executive Vice President John Trizzino gives a short presentation on how the Novavax vaccine works against wild-type SARS-CoV-2, as well as variants…